| Authors: |
Del Águila Á; Institute of Brain, Behavior and Immunology, College of Medicine, The Ohio State University Wexner Medical Center, Columbus, OH, USA., Strehle LD; Institute of Brain, Behavior and Immunology, College of Medicine, The Ohio State University Wexner Medical Center, Columbus, OH, USA., Yiadom SA; Division of Biostatistics, College of Medicine, The Ohio State University Wexner Medical Center, Columbus, OH, USA., Sardesai SD; Division of Medical Oncology, College of Medicine, The Ohio State University Wexner Medical Center, Columbus, OH, USA., Williams NO; Division of Medical Oncology, College of Medicine, The Ohio State University Wexner Medical Center, Columbus, OH, USA., Gatti-Mays ME; Division of Medical Oncology, College of Medicine, The Ohio State University Wexner Medical Center, Columbus, OH, USA., Stover DG; Division of Medical Oncology, College of Medicine, The Ohio State University Wexner Medical Center, Columbus, OH, USA., Sudheendra PK; Division of Medical Oncology, College of Medicine, The Ohio State University Wexner Medical Center, Columbus, OH, USA., Wesolowski R; Division of Medical Oncology, College of Medicine, The Ohio State University Wexner Medical Center, Columbus, OH, USA., Gorka SM; Institute of Brain, Behavior and Immunology, College of Medicine, The Ohio State University Wexner Medical Center, Columbus, OH, USA; Department of Psychiatry and Behavioral Health, College of Medicine, The Ohio State University Wexner Medical Center, Columbus, OH, USA., Andridge RR; Division of Biostatistics, College of Medicine, The Ohio State University Wexner Medical Center, Columbus, OH, USA., Pyter LM; Institute of Brain, Behavior and Immunology, College of Medicine, The Ohio State University Wexner Medical Center, Columbus, OH, USA; Department of Psychiatry and Behavioral Health, College of Medicine, The Ohio State University Wexner Medical Center, Columbus, OH, USA. Electronic address: leah.pyter@osumc.edu. |
